The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Simeon, D.
* Articles by Aronowitz, B.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Simeon, D.
* Articles by Aronowitz, B.

Am J Psychiatry 1995; 152:1207-1209
Copyright © 1995 by American Psychiatric Association


REGULAR ARTICLES

Body dysmorphic disorder in the DSM-IV field trial for obsessive- compulsive disorder

D Simeon, E Hollander, DJ Stein, L Cohen and B Aronowitz

OBJECTIVE: This study investigated the prevalence and phenomenology of body dysmorphic disorder in patients with obsessive-compulsive disorder. METHOD: The authors studied 442 patients who participated in the DSM-IV field trial for obsessive-compulsive disorder. RESULTS: Twelve percent (N = 51) of the patients had a lifetime comorbid diagnosis of body dysmorphic disorder. Patients with and without body dysmorphic disorder did not differ in demographic characteristics of obsessive-compulsive symptoms. Patients with obsessive-compulsive disorder and body dysmorphic disorder had more anxious, impulsive, and schizotypal features than patients with obsessive-compulsive disorder alone. Age at onset was similar for the two disorders, and severity correlated. However, insight was significantly more impaired for body dysmorphic disorder than for obsessive-compulsive disorder. CONCLUSIONS: As previously thought, these findings suggest that the two disorders are strongly related but also have differences that require further investigation.


This article has been cited by other articles:


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
P. Carey, S. Seedat, J. Warwick, B. v. Heerden, and D. J. Stein
SPECT Imaging of Body Dysmorphic Disorder
J Neuropsychiatry Clin Neurosci, August 1, 2004; 16(3): 357 - 359.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
K. A. Phillips, R. S. Albertini, and S. A. Rasmussen
A Randomized Placebo-Controlled Trial of Fluoxetine in Body Dysmorphic Disorder
Arch Gen Psychiatry, April 1, 2002; 59(4): 381 - 388.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. W. Otto, S. Wilhelm, L. S. Cohen, and B. L. Harlow
Prevalence of Body Dysmorphic Disorder in a Community Sample of Women
Am J Psychiatry, December 1, 2001; 158(12): 2061 - 2063.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
E. Hollander, A. Allen, J. Kwon, B. Aronowitz, J. Schmeidler, C. Wong, and D. Simeon
Clomipramine vs Desipramine Crossover Trial in Body Dysmorphic Disorder: Selective Efficacy of a Serotonin Reuptake Inhibitor in Imagined Ugliness
Arch Gen Psychiatry, November 1, 1999; 56(11): 1033 - 1039.
[Abstract] [Full Text] [PDF]


Home page
Behav ModifHome page
D. McKay
Two-Year Follow-Up of Behavioral Treatment and Maintenance for Body Dysmorphic Disorder
Behav Modif, October 1, 1999; 23(4): 620 - 629.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1995 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org